Vice President, Corporate Affairs
Archie Prestayko has over 40 years of experience in the discovery and development of therapeutic prescription drugs in the pharmaceutical industry. Most recently, he was Chairman and CEO of BioStratum and President and CEO of Medco Research. Prior to that, Dr. Prestayko directed research and development in a number of therapeutic areas at Bristol Myers Squibb and Glaxo SmithKline. He takes great pride in his contribution to the regulatory approvals for drugs such as Cisplatinum and other platinum-based drugs. Dr. Prestayko earned his Ph.D. from the University of Tennessee. He subsequently held a faculty position in the Department of Pharmacology at Baylor Medical School in Houston.